Commentary - (2025) Volume 9, Issue 6
Received: 03-Nov-2025, Manuscript No. jchd-26-185717;
Editor assigned: 05-Nov-2025, Pre QC No. P-185717;
Reviewed: 19-Nov-2025, QC No. Q-185717;
Revised: 24-Nov-2025, Manuscript No. R-185717;
Published:
01-Dec-2025
, DOI: 10.37421/2684-6020.2024.9.273
Citation: Lefevre, Claire. ”Women’s Heart Disease: Unmasking
Unique Challenges and Care.” J Coron Heart Dis 09 (2025):273.
Copyright: © 2025 Lefevre C. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,
distribution and reproduction in any medium, provided the original author and source are credited.
Coronary heart disease (CHD) has historically been characterized as a male-predominant illness, which has unfortunately led to its underdiagnosis and undertreatment in women. This prevailing perception stems from a research landscape that has historically concentrated on male physiology, resulting in diagnostic criteria and treatment guidelines that may not adequately encompass the distinct ways CHD manifests in women. A crucial insight is that women frequently present with a different constellation of symptoms, which can include fatigue, shortness of breath, and nausea, rather than the more classic presentation of chest pain. Furthermore, underlying risk factors such as diabetes, hypertension, and microvascular dysfunction are disproportionately prevalent and exert a more significant impact on female cardiovascular health, yet these are often inadequately addressed. Therefore, a comprehensive understanding of these sex-specific differences is absolutely critical for advancing the early detection and effective management of CHD in women [1].
The clinical presentation of acute coronary syndromes in women often diverges significantly from the typical presentation observed in men, underscoring the imperative for heightened awareness among healthcare providers. Symptoms that are commonly reported in women include atypical chest discomfort, dyspnea, diaphoresis, and nausea, which frequently contribute to delays in diagnosis. This review emphasizes the critical importance of considering these subtle or non-chest pain symptoms as potential indicators of cardiac ischemia in women, thereby facilitating more timely and effective intervention and ultimately improving patient outcomes [2].
Microvascular dysfunction plays a substantial role in the pathophysiology of coronary heart disease specifically in women, frequently contributing to conditions such as angina with non-obstructive coronary arteries (ANOCA). This specific condition is often overlooked in clinical practice, leading to significant diagnostic challenges and suboptimal management strategies. This article strongly emphasizes the necessity of employing specialized diagnostic tools and developing tailored therapeutic strategies to effectively address the unique aspects of microvascular disease as it pertains to female populations [3].
The prevalence and overall impact of traditional cardiovascular risk factors, including hypertension and dyslipidemia, manifest differently in women when compared to men. This comprehensive review highlights the increased susceptibility of women to these particular risk factors and details their amplified contribution to the occurrence of cardiovascular events. It rigorously stresses the paramount importance of early and aggressive management of these risks in women as a means to effectively prevent premature cardiovascular disease [4].
Diabetes confers a significantly higher risk of developing coronary heart disease in women than it does in men. This notable disparity is attributed to a complex interplay of various factors, which includes hormonal influences, distinct metabolic differences, and often a tendency towards poorer glycemic control. The article strongly emphasizes the critical need for the development and implementation of tailored diabetes management strategies specifically designed for women to effectively mitigate their elevated cardiovascular risk [5].
The lifetime risk of developing cardiovascular disease is demonstrably higher for women than for men, especially when considering the profound impact of sex-specific factors such as pregnancy complications and the occurrence of early menopause. This paper powerfully underscores the fact that cardiovascular risk assessment in women must meticulously incorporate these unique biological and life-course factors to ensure accurate prognostication and the development of highly effective prevention strategies [6].
Understanding the intricate role of inflammation in the context of women's cardiovascular disease is of paramount importance, as it often presents with unique inflammatory profiles and distinct responses. This article thoroughly explores how various inflammatory processes, including those that are intrinsically linked to autoimmune diseases that are more commonly observed in women, contribute significantly to the development and progression of atherosclerosis and coronary artery disease [7].
The impact of psychological stress on cardiovascular health exhibits notable differences between the sexes, with women often experiencing more pronounced and detrimental effects of chronic stress on their cardiac function and overall risk profile. This research compellingly highlights the critical importance of actively addressing mental health and implementing effective stress management techniques as integral components of both cardiovascular disease prevention and treatment strategies specifically for women [8].
Guideline-directed medical therapy for coronary heart disease may necessitate sex-specific adjustments, given that women can exhibit different responses to certain medications. This review critically examines the existing evidence that supports sex-based differences in pharmacological responses and strongly advocates for the adoption of more personalized treatment approaches in women to optimize therapeutic efficacy and minimize the occurrence of adverse effects [9].
The role of reproductive health factors, such as oral contraceptive use and hormone replacement therapy, in the development of coronary heart disease in women is intricate and warrants careful and thorough consideration. This article provides a comprehensive overview of the various ways in which these factors can influence cardiovascular risk and strongly emphasizes the crucial need for individualized risk assessment and counseling for women concerning these aspects [10].
Coronary heart disease (CHD) is often misconstrued as a condition primarily affecting men, leading to significant challenges in its diagnosis and treatment for women. Historical research biases, focusing predominantly on male physiology, have resulted in diagnostic criteria and treatment guidelines that may not fully account for the unique ways CHD presents in women. Key findings indicate that women frequently experience atypical symptoms such as fatigue, shortness of breath, and nausea, diverging from the classic chest pain often associated with men. Moreover, underlying risk factors like diabetes, hypertension, and microvascular dysfunction are disproportionately prevalent and impactful in female cardiovascular health but are often inadequately addressed. Recognizing these sex-specific nuances is crucial for improving early detection and management of CHD in women [1].
The presentation of acute coronary syndromes in women often deviates from the typical male presentation, necessitating heightened awareness among healthcare professionals. Symptoms like atypical chest discomfort, dyspnea, diaphoresis, and nausea are common, frequently causing diagnostic delays. This review emphasizes the importance of recognizing these subtle or non-chest pain symptoms as potential indicators of cardiac ischemia in women, thereby enabling prompt intervention and improving patient outcomes [2].
Microvascular dysfunction plays a significant role in the pathophysiology of coronary heart disease in women, often leading to angina with non-obstructive coronary arteries (ANOCA). This condition is frequently overlooked, resulting in diagnostic difficulties and suboptimal management. The article highlights the need for specialized diagnostic tools and therapeutic strategies to address the unique aspects of microvascular disease in the female population [3].
The prevalence and impact of traditional cardiovascular risk factors, such as hypertension and dyslipidemia, differ between sexes. This review points out the increased susceptibility of women to these factors and their amplified contribution to cardiovascular events, stressing the importance of early and aggressive risk management in women to prevent premature cardiovascular disease [4].
Diabetes significantly elevates the risk of coronary heart disease in women compared to men, attributed to a complex interplay of hormonal influences, metabolic differences, and often poorer glycemic control. The article underscores the critical need for tailored diabetes management strategies for women to mitigate their heightened cardiovascular risk [5].
Women face a higher lifetime risk of cardiovascular disease than men, particularly when considering sex-specific factors like pregnancy complications and early menopause. This paper emphasizes that cardiovascular risk assessment in women must incorporate these unique biological and life-course factors for accurate prognostication and effective prevention [6].
Understanding the role of inflammation in women's cardiovascular disease is critical due to unique inflammatory profiles and responses. The article examines how inflammatory processes, including those related to autoimmune diseases common in women, contribute to the development and progression of atherosclerosis and coronary artery disease [7].
Psychological stress affects cardiovascular health differently between sexes, with women often experiencing more pronounced impacts of chronic stress on cardiac function and risk. This research highlights the importance of addressing mental health and stress management in cardiovascular disease prevention and treatment for women [8].
Guideline-directed medical therapy for coronary heart disease may require sex-specific adjustments, as women can respond differently to certain medications. This review explores evidence for sex-based differences in pharmacological responses and advocates for personalized treatment approaches in women to optimize efficacy and minimize adverse effects [9].
The role of reproductive health factors, including oral contraceptive use and hormone replacement therapy, in the development of coronary heart disease in women is complex and requires careful consideration. This article reviews how these factors influence cardiovascular risk and stresses the need for individualized risk assessment and counseling for women [10].
Coronary heart disease (CHD) is often underdiagnosed and undertreated in women due to historical biases focusing on male physiology. Women present with different symptoms, and risk factors like diabetes and hypertension have a more significant impact. Microvascular dysfunction is a key issue, leading to angina with non-obstructive coronary arteries. Cardiovascular risk assessment must consider sex-specific factors, including reproductive health and pregnancy complications. Inflammation and psychological stress also play distinct roles in women's cardiovascular health. Treatment strategies, including medications, may require sex-specific adjustments. Early and aggressive management of risk factors is crucial for preventing premature cardiovascular disease in women.
Journal of Coronary Heart Diseases received 15 citations as per Google Scholar report
